By Dean Seal
Elicio Therapeutics has hired the former chief financial officer of Cidara Therapeutics to lead its strategy and finances.
The Boston-based Elicio said Monday that Preetam Shah has been appointed chief strategy and financial officer.
Shah will also serve as the biotechnology company's principal financial officer and principal accounting officer.
He most recently served as the chief financial officer and chief business officer of fellow biotech Cidara. Before that, Shah was the CFO for Brainstorm Cell Therapeutics and has held roles at Barclays Capital and Canaccord Genuity.
Write to Dean Seal at dean.seal@wsj.com
(END) Dow Jones Newswires
March 24, 2025 07:46 ET (11:46 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。